• Scenario-Driven Best Practices with JNJ-26854165 (Serdemetan

  2026-04-22

  This article provides a scenario-driven, evidence-based playbook for cell viability and apoptosis assays leveraging JNJ-26854165 (Serdemetan) (SKU A4204). Drawing on published data and real-world laboratory challenges, we demonstrate how this HDM2 ubiquitin ligase antagonist from APExBIO supports reproducible, high-confidence results in cancer research.

• EZ Cap Cy5 Firefly Luciferase mRNA: Quantitative Tracking &

  2026-04-22

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables quantitative mRNA delivery tracking and assay optimization. Discover unique workflow insights, microfluidic manufacturing advances, and practical protocols for dual-mode bioluminescence and fluorescence applications.

• Dual-Network Hydrogel Microspheres Mitigate IVDD via Apoptos

  2026-04-21

  This study introduces a multifunctional dual-network hydrogel microsphere system for targeted delivery of miR-155 and chitooligosaccharide to nucleus pulposus cells (NPCs), effectively reducing inflammation and apoptosis in intervertebral disc degeneration (IVDD) models. The findings highlight a promising approach for addressing the complex pathophysiology of IVDD by combining mechanical support, controlled drug release, and modulation of key degenerative pathways.

• Valemetostat in Lymphoma Research: Protocols, Use Cases & Pr

  2026-04-21

  Valemetostat (DS-3201) delivers robust, selective inhibition of EZH2—including clinically relevant Y641, A677, and A687 mutants—enabling advanced epigenetic cancer therapy and reproducible results in lymphoma models. This guide dissects practical workflows, data-driven troubleshooting, and experimental advantages, mapping reference-backed innovation to actionable laboratory protocols.

• Technical Guide: Angiotensin I/II (1-5) in RAS Workflows

  2026-04-20

  Angiotensin I/II (1-5) offers researchers a defined Asp-Arg-Val-Tyr-Ile peptide fragment specifically for modeling blood pressure regulation and aldosterone release within the renin-angiotensin system. It is appropriate for cardiovascular and renal physiology workflows, but should not be used in unrelated peptide or signaling studies due to its narrow mechanistic scope.

• PP2A-Driven Autophagy and Drug Resistance in Candida albican

  2026-04-20

  This article examines how protein phosphatase 2A (PP2A) modulates autophagy-related protein phosphorylation to enhance biofilm formation and drug resistance in Candida albicans. The findings clarify a mechanistic link between autophagy and antifungal resistance, supporting new strategies for targeting biofilm-associated infections.

• 5-hme-dCTP: Precision Epigenetic DNA Modification in Plants

  2026-04-19

  Unlock next-generation epigenetic DNA modification research with 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate). This guide translates breakthrough plant drought response findings into actionable workflows, troubleshooting tips, and strategic assay enhancements—enabling researchers to dissect DNA hydroxymethylation dynamics with unprecedented resolution.

• Piezo2-Driven Neuroinflammation in Trigeminal Neuralgia Allo

  2026-04-18

  Liao et al. reveal that chronic compression of the trigeminal root induces a neuroinflammatory cascade, linking ATP-driven Ca2+ signaling to upregulation of Piezo2 and neuropeptides CGRP and SP in trigeminal neuralgia (TN). This study clarifies a mechanistic positive feedback loop that underlies mechanical allodynia, offering new molecular targets for pain management research.

• ApexPrep DNA Plasmid Miniprep Kit: Precision DNA for Advance

  2026-04-17

  Discover how the ApexPrep DNA Plasmid Miniprep Kit delivers molecular biology grade plasmid DNA for high-stakes applications in acute myeloid leukemia (AML) research. This article provides a unique, evidence-driven analysis of workflow optimization, reference-based assay design, and critical decision points for translational science.

• Probenecid: Precision Tool for Multidrug Resistance and Neur

  2026-04-16

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) stands out as a dual-action research reagent, enabling both multidrug resistance reversal in tumor models and neuroprotection in ischemia/reperfusion injury workflows. This guide demystifies its integration into advanced protocols, offering stepwise experimental strategies and practical troubleshooting informed by the latest literature.

• Practical Guide to Dimethyloxalylglycine (DMOG) Use in Hypox

  2026-04-15

  Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor that enables controlled hypoxia-inducible factor (HIF) stabilization, supporting hypoxia signaling and inflammation research in vitro and in vivo. This compound is best suited for mechanistic studies where precise, reversible PHD inhibition and HIF-1α stabilization are required. It should not be used for diagnostic or therapeutic applications.

• Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitio

  2026-04-14

  Oligomycin A, a gold-standard mitochondrial ATP synthase inhibitor from APExBIO, unlocks advanced control over mitochondrial bioenergetics and metabolic adaptation assays. This guide delivers actionable protocols, troubleshooting strategies, and practical insights—bridging cutting-edge immunometabolic findings with reproducible experimental workflows.

• Toremifene in Prostate Cancer: Applied Workflows & Key Innov

  2026-04-13

  Toremifene, a potent selective estrogen-receptor modulator, empowers researchers to dissect hormone-dependent cancer pathways and calcium signaling in advanced prostate cancer models. This article translates cutting-edge findings on the TSPAN18-STIM1 axis into actionable protocols, troubleshooting guidance, and strategic advantages for hormone-responsive cancer research.

• Rotenone as a Mitochondrial Complex I Inhibitor: Advanced Wo

  2026-04-13

  Rotenone serves as a benchmark mitochondrial Complex I inhibitor for modeling mitochondrial dysfunction, autophagy, and neurodegenerative disease pathways. This guide details evidence-driven protocols, troubleshooting strategies, and key innovations that enable precise, reproducible outcomes in advanced cellular and animal research.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Models

  2026-04-12

  This study demonstrates that activation of the BMP4-GPX4 pathway reduces ferroptosis and enhances differentiation of retinal stem cells (RSCs) into retinal ganglion cells (RGCs) following transplantation in a mouse model of glaucoma with high intraocular pressure. The findings provide a mechanistic basis for targeting ferroptosis in neurodegenerative disease models and inform experimental approaches for evaluating stem cell-based neuroprotection.

16454 records 1/1097 page Next 12345 下5页 Last page